ASSEMBLY FINANCIAL INSTITUTIONS AND INSURANCE COMMITTEE

STATEMENT TO

[First Reprint]

SENATE, No. 2886

STATE OF NEW JERSEY

DATED:  MAY 15, 2025

      The Assembly Financial Institutions and Insurance Committee reports favorably Senate Bill No. 2886 (1R).

This bill requires pharmacies to provide certain information regarding insulin manufacturer assistance programs.

     Under this bill, a pharmacy practice site will be required to display, in a conspicuous manner, a notice on its website, concerning insulin manufacturer assistance programs at all points of sale, the details of which are to be drafted by the Department of Health.  A pharmacy practice site is also required to provide, upon the request of an individual, a pamphlet created by the department concerning insulin manufacturer assistance programs.  Insulin manufacturers offering an assistance program may inform the department of their intention to be included in the notices and pamphlets.  The effective date of the bill is twelve months from the date it is signed into law.

      As reported by the committee, Senate Bill No. 2886 (1R) is identical to Assembly Bill No. 4015, which was also amended and reported by the committee on this date.